Endevica Bio
PrivateLast Round
Series B
Jan 19, 2023
Total Funding Raised
$11.7M
Momentum Score
50 /100
Company Overview
Endevica Bio is a biotechnology company that develops first-in-class peptide drug candidates for the treatment of cachexia caused by cancer and other chronic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endevica Bio Comps
Public and private peers based on sector, stage, and business model.
Endevica Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 19, 2023 | ||||
| Seed | Jun 1, 2016 |
Key People
Founding team and executive leadership
Endevica Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centennial Investors | Seed, Series B |
| Missouri Technology Corporation | Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 28, 2025
Developing a peptide therapeutic drug to combat cachexia.
- Apr 18, 2025
Phase 2 trial initiated for B07, a cancer weight loss treatment.
Endevica Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Endevica Bio's valuation, stock price, and market status.
